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Abstract
Mice deficient for the fifth component of murlne complement (C5), unlike normal mice, do not
possess the secreted form of C5 in their body fluids and can be readily Immunized to
serum-derived normal C5. Although macrophages from C5-deficient mice do not secrete C5, they
synthesize the precursor form (pro-C5). Therefore contact of T cells with autologous pro-C5
presented by macrophages Is theoretically possible. We show that macrophages from
C5-deflclent mice can Indeed stimulate a class II restricted C5-speclfic T cell clone without
addition of exogenous C5. Immunization of C5-deficient mice with autologous pro-C5 Induces
vigorous C5-speclfic T cell proliferation and pro-C5 Is recognized by C5-speciflc T cells In vitro,
demonstrating that this protein falls to Induce tolerance under physiological conditions. Thus,
intracellular pro-C5 is processed and presented by C5-deficlent macrophages and can activate T
cell clones In vitro, yet Is neither immunogenic nor tolerogenlc for T cells In vivo.
Introduction
The fifth component of munne complement (C5) is a self
antigen that is normally present in plasma at a concentration
of - 1 0 - 7 M (1). The widespread occurrence in the mouse
population of a spontaneous mutation affecting synthesis and
secretion of C5 has generated a natural model for studies of self
tolerance (2,3). Mice deficient for C5 do not possess secreted
C5 protein and as a consequence are not tolerant of C5
Immunization with normal serum results in generation of
C5-specific antibodies (2,3) and CD4 + T cells that recognize C5
in the context of class II MHC (4).
Tolerance induction presumably involves self molecules
expressed by cells in the thymus as well as secreted proteins
which can reach the thymus to be presented to developing T
cells. In C5-sufficient mice which do not generate anti-C5 T cell
responses, endogenous secreted C5 is processed and presented
by antigen-presenting cells in thymus and periphery (4), allowing
induction and maintenance of tolerance. Although C5-deficient
mice are devoid of secreted C5, their macrophages (and
hepatocytes) synthesize a single-chain precursor molecule
(pro-C5) (5). In normal mice pro-C5 is subsequently cleaved and
secreted as a disulfide-linked heterodimer (6). A defect at a yet
undefined site reduces the rate of synthesis of pro-C5 in
C5-deficient macrophages and prevents its modification and
secretion (5,7).
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The synthesis of pro-C5 in macrophages, which process and
present not only exogenous but also endogenous proteins (8,9),
raises the question of whether this molecule is presented and
recognized by T cells from C5-deficient donors.
In this paper we show that macrophages from C5-deficient
mice indeed present their endogenous pro-C5 which can activate
T cell clones in vitro. However, T cells in vivo appear to ignore
this self antigen so that, as a consequence, neither tolerance nor
autoimmunity is induced
Methods
Mice
B10.D2/oSn (O) and B10.D2/nSn (N) mice were obtained from
the Jackson Laboratories, Bar Harbor, ME and maintained in
the Basel Institute animal facilities.
T cell proliferation assays
Draining lymph nodes from mice immunized in the base of the
tail 8 -10 days previously were aseptically removed and cell
suspensions were prepared. C5-specrfic proliferation assays were
set up as described (4) Briefly, 4 x 105 responding lymph
node cells/well of flat-bottom, 96-well culture plates (Costar) were
Received 1 July 1989, accepted 15 August 1989
Failure of tolerance induction to an intracellular self antigen 593
cultured in 0.2 ml total volume of Iscove's modified Dulbecco
medium supplemented with 5% fetal calf serum (FCS; Gibco),
5 x 10-5 M mercaptoethanol, 2 x 10~3M L-glutamine, and
100 /tg/ml gentamycm. Cultures were incubated for 3 days with
affinity-purified C5 antigen prepared as described (10). For the
last 20 h 1 /iCi/well [3H]thymidine was added Cultures were
harvested and counted in a liquid scintillation counter.
Preparation of liver extracts
Liver extracts from O and N were prepared as described (11).
Briefly, livers were homogenized in 1 1 (w/v) PBS containing
1 mM PMSF. They were then spun at 11,000 g for 30 mm The
supernatants were extracted with chloroform and spun at 10,000
g for 1 h. The resulting supernatants were once more spun at
35,000 g for 40 min
Precipitation of pro-C5
Liver extracts were precleaned by addition of protein A -
Sepharose. Pro-C5 in liver extracts was precipitated by addition
of 50 j*g of the IgG fraction of a polyclonal anti-C5 antiserum per
2 g original liver input Precipitates were bound by addition of
protein A-Sepharose, washed extensively with PBS containing
1 mM EDTA, and then emulsified in complete Freund's adjuvant
(CFA) For use in culture, pro-C5 from 5 g of C5-deficient liver
was immunoprecipitated and subsequently eluted with 1 ml of
1 M KBr and then dialyzed against PBS.
Immunization
Mice were immunized in the base of the tail with 100 /J antigen
preparation emulsified in CFA Serum-derived C5 was prepared
by precipitating the euglobuhn fraction of serum containing C5
as described (2). Mice received ~25^g C5, assuming a
concentration of 50 /ig/ml serum.
Establishment of C5-specific T cell clones and hybrids
The generation of C5-specific T cell clones and hybrids has been
described in detail (4).
Assay for evaluation of IL-2 production
The IL-2-dependent T cell line CTLL was cultured at 5 x 103
cells/well with supernatants to be tested for their IL-2 content.
Culture medium provided the negative control. After 24 h, 1 ^ Ci
[3H]thymidine was added per well and cultures were harvested
6 h later
Enrichment of antigen-presenting cells (APC)
Because of their low buoyant density, APC can be isolated
on discontinuous Percoll gradients. Thymus or spleen cell
suspensions were prepared and 2 x 107 cells were layered on
a gradient consisting of Percoll density 1.074 followed by
densities 1 062 and 1.05 in 11 ml polycarbonate tubes (Nunc)
These tubes were spun at 5000 g for 20 min and APC were
isolated from the low-density fraction between densities 1.05 and
1 062. The recoveries were -7% from spleen and 0.4% from
thymus.
Preparation of different feeder cell populations
O adherent cells (enriched for macrophages) were prepared by
adsorption of spleen cells on 35 mm tissue culture dishes (Nunc)
for 1.5 h Non-adherent cells were removed by vigorous washing
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Fig. 1. C5-specific T cetl proliferation after immunization with precipitates
from liver or serum Three O mice per group were immunized in the base
of the tail with immunoprecipitates emulsified in CFA of either N serum
equalling - 1 0 fig C5/mouse, N liver equalling one liver equivalent and
O liver equalling four or one liver equivalents, respectively A control group
of N mice was injected with N liver precipitate Nine days later cells from
draining lymph nodes were pooled and assayed for C5-specific
proliferation in the presence of 40 iiglrn\ affinity-purified C5. Control wells
received medium or an irrelevant antigen, ovalbumm Tuberculin PPD
(50 nglm\, Statens Institute) provided a positive control [3H]Thymidine
uptake (cpm) after 72 h of culture is shown.
and adherent cells were subsequently removed by addition of
PBS containing 1 mM EDTA
O B cells were prepared by panning spleen cells from
C5-immune O mice on Petri dishes (Optilux, Falcon) coated with
a 1/1000 dilution of ascrtes from monoclonal anti-Thy 1.2 antibody
6-68. Non-adherent cells were subsequently subjected to two
sequential rounds of adsorption on 35 mm tissue culture dishes
to remove macrophages. B cells were activated with 30 nglm\
LPS for 24 h
O T cells were isolated by nylon wool passage of lymph node
cells.
Treatment with y-interferon (y-IFN)
APC from thymus and spleen were incubated in 96-well,
round-bottom tissue culture plates with 250 U/ml recombinant
rat 7-IFN for 24 h. The medium was then discarded and the plates
were washed once with prewarmed culture medium.
Activation of T cell clones with fibroblast APC
Fibroblast APC (1 x 105/well; ref. 12, CA36.2.1 li) were pulsed
with antigen for 6 h at 37°C, subsequentty washed and irradiated
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Table 1 . T cell reactivity to pro-C5 in vitro
Responder Medium3 pro-C5 C5 PR8 virus
C5 hybrid HA2
C5 hybrid C8-15
Influenza hybrid BV2-15
143 ± 5
11,622 ± 403
167 ± 23
45,545 ± 3218
47,386 ± 1209
193 ± 57
45,781 ± 2226
42,628 ± 1083
225 ± 167
285 ± 112
9432 ± 1543
59,252 ± 627
1 x 105 cells/well from hybrid HA2, C8-15, or BV2-15 were cultured with 1 x 105/well CA36.2.1 h fibroblast APC. APC were pulsed for 6 h at
37°C with either medium or affinity-purified C5 (5/tg/ml) or pro-C5 immunoprecipitated from extracts of 5 g B10.D2/O livers Immunoprecipitated
material was eluted from Sepharose beads with 1 M KBr and dialyzed against PBS before addition to the APC After the 6 h pulse, APC were washed
three times and irradiated 10,000 rad PR8 virus antigen (10 U/ml) was added to irradiated APC together with responder cells rather than pre-pulsed
on APC. After 24 h of culture, 100 *tl of supernatant were transferred to a fresh 96-well culture plate containing 5000/well IL-2-dependent CTLL cells
for another 24 h culture period For the last 6 h 1 ^Ci/well [3H]thymidine was present Results are expressed in mean com of thymidme upake ± SD.
aVaJues represent cpm x 10~3
with 10,000 rad. They were cultured with 2 x 1CH/well cloned
T cells for 24 h. One hundred microliters of supernatants were
then transferred to wells containing 5 x 103 CTLL cells for
assessment of IL-2 production
Immunization with Listena monocytogenes
Mice were immunized i v with 5 x 104 live Listena (a gift from
Dr Stefan Kaufmann, Ulm)
Results
T cell reactivity of C5-deficient mice to autologous C5
To test T cell reactivity to autologous pro-C5, liver extracts from
C5-deficient B10.D2/0 (O) mice and the congenic C5-sufficient
strain B10.D2/n (N) were prepared and pro-C5 was precipitated
with polyclonal anti-C5 antibody Precipitate from N and 0
liver extracts showed a single band of mol. wt -180,000
corresponding to pro-C5 on SDS gels run under reducing
conditions. Precipitates from N serum showed the two chains
of secreted C5. The concentration of O pro-C5 was estimated
to be -8-fold lower than N pro-C5 (data not shown)
C5-deficient O mice and one group of C5-sufficient N mice
were immunized in the base of the tail with precipitates in CFA
They either received one liver equivalent of N or O or four liver
equivalents of O, and N serum precipitate containing - 10 fig C5
The results presented in Fig. 1 clearly show that immunization
with N serum precipitate, N liver precipitate, and 0 liver precipitate
equalling four liver equivalents induced comparable C5-specific
proliferation. Priming with one liver equivalent of O, which was
estimated to contain -8-fold less precipitated pro-C5, induced
low but detectable proliferation. Absence of proliferation to the
control antigen ovalbumin, as well as the failure of N mice
immunized with N liver precipitate to respond to C5 in culture,
excluded potential non-specific activation by protein A or antibody
in the priming inoculum.
All O mice, with the exception of those immunized with one
liver equivalent of O, generated C5-specrfic antibodies which were
predominantly IgG, (data not shown). No antibody responses
to C5 were detected in N mice regardless of the mode of
immunization. These data provide evidence that T cells from
C5-deficient mice are not tolerized to autologous pro-C5.
Pro-C5 from C5-deficient mice is immunogenic in vitro
Pro-C5 immunoprecipitated from C5-deficient livers can prime
mice for C5-specific responses as shown in the previous
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Fig. 2. ProWerative response of clone T58C8 in the presence of different
O feeder cells. 2 x 104 cells/well of clone T58C8 were cultured in the
presence of various doses of 3000 rad irradiated spleen adherent cells
( • ) , LPS-achvated B ceils (O), or T cells (A) without (left panel) or with
(right panel) 5 M9/ml C5 for 72 h; 1 ^ Ci/well [3H]thymidine was added
for the last 20 h
experiment. Its immunogenicity in vitro could not be tested in
T cell proliferation assays since pro-C5 could not be further
purified because the monoclonal antibody used for affinity
purification of C5 does not cross-react with intracellular pro-C5.
To circumvent this problem we took advantage of C5-specific
T cell hybrids which secrete IL-2 upon culture with l-Ed-bearing
APC and C5 (4). For the following experiment we used I-Ed-
bearmg fibroblasts (13) which had been supertransfected with
the invariant chain gene (CA36.2.1 h) and were extremely potent
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spleen thymus spleen thymus spleen thymus spleen thymus
Table 2. Absence of autoimmune reactivity in Listeria primed
mice
Fig. 3. C5-presenting capacity of spleen and thymus APC before and
after treatment with 7-IFN. APC from thymus and spleen were isolated
on discontinuous Percoll gradients. 2 x 105 APC/well were treated with
either medium or 250 U/ml recombinant rat 7-IFN in 96-well, round-bottom
tissue culture plates for 24 h. 2 x 104 cells/well of clone T58C8 were
added to either non-treated APC or 7-IFN-treated APC in the absence
or presence of 5 /ig/ml C5 and cultured for 72 h. For the last 20 h,
1 /tCi/well [3H]thymidine was added to the wells.
APC (12). They were pulsed with either affinity-purified C5 or
pro-C5 immunoprecipitated from C5-deficient livers, or C5
precipitated from normal serum and subsequently cultured with
the C5-specific T cell hybrids C8-15 and HA2 for 24 h. Table 1
shows that not only normal C5 but also pro-C5 from C5-deficient
mice was capable of activating these hybrids for IL-2 secretion.
A T cell hybrid specific for influenza hemagglutinin was not
stimulated by fibroblasts pulsed with C5 or pro-C5. We can
conclude that C5-specific T cells are not tolerized to pro-C5 but
recognize 'foreign' secreted C5 just as well as autologous pro-C5
which is still synthesized in C5-deficient mice.
Reactivity of T cells to pro-C5 presented by autologous
macrophages
In vivo autologous pro-C5 does not appear in the circulation of
C5-deficient mice and so cannot be processed and presented
by every class ll-bearing APC. The only cells that might present
pro-C5 in C5-deficient mice are macrophages which synthesize
this molecule themselves. Therefore it was of interest to test if
T cells from C5-deficient mice could perceive autologous pro-C5
presented by macrophages in the absence of any exogenously
added antigen. For these experiments, spleen cells from
C5-deficient O mice were either enriched or depleted of M$ and
tested for their antigen-presenting capacity to the C5-specific T
cell clone T58C8 with or without exogenously added C5.
As shown in Fig. 2, T58C8 proliferated vigorously after culture
with 0 adherent spleen cells that were enriched for macrophages
in the presence or absence of C5. In contrast, feeder cells
enriched for activated B cells and depleted for adherent cells
were excellent APC for exogenously added C5 but they did not
stimulate the clone in the absence of C5. Nylon wool-purified T
Antigen B10.D2/Na B10.D2/O
Exp. 1
Exp. 2
C5
Listeria
C5
Listeria
13,252
11,824
109,604
4769
4934
56,544
7393
6350
76,571
3627
4287
69,967
O and N mice were immunized twice with an interval of 1 week with
5 x 104 live Listeria i.v. For experiment 1, spleen and lymph node cells
from three mice were pooled 8 days after the second immunization.
5 x 105 responder cells/well of a 96-well culture plate were cultured with
20/ig/ml C5 or 107 heat-killed Listeria for 72 h. For the last 20 h,
1 (iCi/well thymidine was present. For experiment 2, spleen and lymph
node cells from three mice 8 days after the second immunization were
passed over nylon wool columns. 5 x 105 responder cells/well were
cultured with 3 x 105/well 3000 rad irradiated spleen cells from
untreated B10.D2/O mice in the presence or absence of C5 or Listeria
as stated above.
aValues represent cpm x 10~3.
cells could not stimulate the clone whether C5 was added or not.
This indicates that autologous intracellular pro-C5 is
immunogenic for class II MHC-restricted T cells of C5-deficient
mice, not only after exogenous application in CFA but also in
its native form presented by macrophages from C5-deficient
donors.
These results raise a puzzling paradox: given that pro-C5
presented by autologous macrophages is immunogenic for T
cells, why are they not tolerized during thymic differentiation?
C5-presenting capacity of spleen and thymus APC
Lack of tolerance to pro-C5 might be the consequence of a
combination of quantitative effects. Obviously the concentration
of pro-C5 is lower in macrophages from C5-deficient mice than
in C5-sufficient mice both at the level of mRNA (7) and at the
protein level (our experiments with liver extracts).
In addition, class II MHC expression on macrophages is not
constitutive (14) and, although macrophages in thymus have
been reported to express class II (15), the levels of expression
are low (16) so that peptides from pro-C5 might not be
appropriately presented to class II MHC-restricted T cells.
Indeed, we found that thymus APC isolated by density gradient
centrifugation could not present endogenous pro-C5 to clone
T58C8 in contrast to spleen APC. Addition of exogenous C5
induced vigorous proliferation both with spleen and thymus APC,
indicating that thymus APC contain dendritic cells that are
constitutively class II MHC positive and can present exogenous
C5. However, after treatment of thymus and spleen APC with
recombinant rat 7-IFN, which induces MHC class II expression
on macrophages (17) prior to addition of the T cell clone, thymus
APC were capable of presenting endogenous pro-C5 (Fig. 3).
These data support the assumption that the apparent deficiency
of class II expression on thymic macrophages under physiological
conditions may be one of the reasons that prevent induction of
tolerance to pro-C5 during thymic ontogeny of T cells.
Absence of autoimmune anti-C5 reactivity in C5-deficient mice
Given the finding that T cells in C5-deficient mice are not tolerized
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to pro-C5, one might expect development of autoimmune T cell
responses triggered by recognition of class II positive, pro-C5-
presenting macrophages in the periphery. However, we have
failed to detect any C5-specific T cell reactivity in the absence
of prior in vivo priming with C5.
It has been stated previously that the magnitude of a T cell
response is determined by the product of concentration of antigen
and MHC (18). Increasing one of the two parameters might be
a means to stimulate an otherwise non-detectable T cell response.
Likewise, we reasoned that up-regulation of MHC class II
expression on macrophages might tip the physiological balance
in C5-deficient mice in favor of triggering an autoimmune
C5-specific response.
It is well documented that macrophage class II expression is
up-regulated in the course of bacterial infection, most notably
with intracellular pathogens like Listeria monocytogenes (19),
mycobactenum tuberculosis (20), or Trypanosoma cruzi (21). In
order to test if increasing the amount of macrophage class II
would allow priming of C5-specific T cells, we immunized O or
N mice with Listeria monocytogenes and tested for C5-specific
T cell proliferation at various time points after secondary
immunization. In no case could we detect C5-specific reactivity.
Two representative experiments are shown in Table 2. For
experiment 1 we used spleen and lymphocyte cells from Listena-
primed mice 8 days after the second immunization. For experi-
ment 2 we enriched for T cells and depleted macrophages by
passage of spleen and lymph node cells over nylon wool. In the
latter case, fresh syngenic spjeen cells were added to the cultures
to provide purified responder T cells with APC. In both types of
experiments we consistently obtained good L/sfena-specific T cell
responses but no C5-specific response.
So it appears that recognition of this intracellular self antigen
in vivo does not occur even under conditions that induce strong
MHC class II expression on pro-C5 synthesizing macrophages.
Discussion
C5-deficient mice are known not to be tolerant of C5 protein
present in serum of normal mice. In this paper we present
evidence that lack of tolerance extends to the intracellular
precursor molecule pro-C5 which is synthesized but not secreted
by C5-deficient macrophages (and hepatocytes).
Immunization with pro-C5-primed C5-deficient mice for
C5-specific T cell responses and C5-specific T cells were capable
of recognizing pro-C5 in vitro.
It is worth emphasizing that from the point of T cell recognition
pro-C5 and C5 probably do not differ since conversion of the
single-chain precursor to the functional heterodimer only removes
four amino acids and retains the rest of the sequence (22).
Deficient pro-C5 may have additional residues recognizable by
T cells since it is slightly larger than normal pro-C5 (7).
Nevertheless, our data clearly show that T cell responses to C5
and deficient pro-C5 overlap
Lack of tolerance to pro-C5 could indicate that this intracellular
self protein is normally secluded from recognition by the immune
system so that T cells encounter it like a foreign antigen upon
immunization.
However, the finding that some C5-specific T cell clones
(represented by T58C8) can recognize autdogous pro-C5 in its
native form presented by C5-deficient macrophages supports
the assumption that this intracellular self antigen can be perceived
by class ll-restricted T cells. These clones appear to have a high
affinity for antigen because they can be activated by 5- to 10-fdd
lower doses of antigen presented by fibroblast APC, compared
with other clones that do not show stimulation by C5-deficient
macrophages in the absence of exogenous antigen (data not
shown).
Investigations of the antigenic requirements for activation of
MHC-restricted T cell responses have provided evidence for the
existence of distinct presentation pathways (reviewed in 23) Class
I MHC-restricted T cells seem to be preferentially activated by
peptides generated from endogenous proteins which associate
with class I MHC (24) while exogenous antigen processed in the
low pH milieu of endosomes seems to associate preferentially
with class II molecules to trigger class ll-restricted T cells (25).
In contradiction to an absolute separation of these pathways is
the recent description by Weiss and Bogen (26) of presentation
of an endogenous lambda light chain determinant to class
ll-restricted T cells. Our data describing recognition of an
endogenous, non-secreted protein by class II MHC-restricted
cells indicate that at least some pro-C5 peptides have access
to the class II presentation pathway.
However, presentation of pro-C5 peptides with class II MHC
does not appear to be efficient enough in vivo to ensure induction
of tolerance to this self antigen
Furthermore, there are no obvious signs of autoimmumty in
C5-deficient mice despite the fact that C5-deficient macrophages
from spleen were shown to activate efficiently some C5-specific
T cell clones. There are several quantitative factors influencing
presentation of this self antigen that probably contribute to the
finding that macrophage pro-C5 is ignored by the immune
system. Firstly, the amount of antigen available to stimulate T cells
is low since C5-deficient macrophages synthesize - 10-fold less
pro-C5 than normal macrophages. Secondly, the generally low
and regulated expression of class II on macrophages might
normally be insufficient to reach the triggering threshold for
activation of C5-specific T cells in vivo In support of this
assumption, we have shown that thymus APC could not activate
a T cell clone in the absence of exogenous antigen unless they
were previously treated with 7-IFN. This effect is most likely due
to an increase in class II MHC expression since C5 synthesis
in contrast to synthesis of other complement components, like
factor B and C2, is not induced by 7-IFN (27).
On the other hand, stimulation of class II expression on
macrophages in the periphery following Listeria infections did
not result in activation of C5-specific T cells. This would indicate
that a mere increase in class II on macrophages, which to some
degree would also occur as a consequence of any ongoing
immune response, does not suffice for recognition of pro-C5 by
T cells. However, in view of the recently described interference
of Listeria infection with macrophage presentation of other
antigens, we cannot exclude the possibility that presentation of
pro-C5 was prevented by Listeria infection (28).
A third quantitative factor influencing presentation of pro-C5
by C5-deficient macrophages could concern the biosynthetic
pathway of this defective protein. It is conceivable that the majority
of peptides resulting from the degradation of endogenous
deficient pro-C5 appear in a cell compartment where they would
preferentially associate with class I MHC and only a few peptides
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would have access to the class II presentation route.
The unusual restriction in expression of a self antigen to
macrophages that are potential, but not constitutive, APC for class
ll-restricted T cells offers the possibility to study qualitative and
quantitative factors of antigen presentation. Regulation of this
function could have crucial implications for development of
autoimmunity.
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